StockData
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. (EBS) stock

EBSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3074% below fair value
$5.61−0.20 (-3.44%)

Close on Nov 17, 2026Market cap $287.64MP/E –Yield –

Emergent BioSolutions market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Emergent BioSolutions's market cap was $309.85M on Nov 11, 2026, against $588.66M a year earlier. Over the last 5 years it ranged from $86.51M to $2.51B, with a median of $441.72M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$309.85M-52.4%
2025Dec 31, 2025$651.37M+25.9%
2024Dec 31, 2024$517.20M+316.0%
2023Dec 29, 2023$124.32M-78.9%
2022Dec 30, 2022$589.32M-74.8%
2021Dec 31, 2021$2.33B-50.8%
2020Dec 31, 2020$4.75B+70.6%
2019Dec 31, 2019$2.78B-6.4%
2018Dec 31, 2018$2.98B+54.7%
2017Dec 29, 2017$1.92B+44.6%
2016Dec 30, 2016$1.33B-14.5%
2015Dec 31, 2015$1.56B+52.2%
2014Dec 31, 2014$1.02B+22.5%
2013Dec 31, 2013$834.79M+43.8%
2012Dec 31, 2012$580.71M-3.9%
2011Dec 30, 2011$604.03M-17.9%
2010Dec 31, 2010$736.06M–

More Emergent BioSolutions figures

See a number that looks wrong?